• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Revive Therapeutics Ltd (OP: RVVTF )

    0.0101 -0.0006 (-5.61%)
    Streaming Delayed Price Updated: 11:08 AM EDT, Jul 29, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Revive Therapeutics Ltd

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Psyched: Canada's Case For Psilocybin Access And Microdose Trial, US Reform Update, Battle With DEA & More
    Canadian Patients Demand Access To Psilocybin: Federal Lawsuit, Official Petition & Failing Mechanism A patient-led lawsuit against the Canadian government is claiming access to therapeutic psilocybin... 
    Via Benzinga
    MDMA Transdermal Patch Moves Toward First-In-Human Trials: Latest Development Update
    Specialty drug delivery technology biopharma company Revive Therapeutics Ltd. (OTCQB: RVVTF) is undertaking research and development activities for its proprietary transdermal microneedle patch to... 
    Via Benzinga
    Meth Use Disorder Tackled With Psilocybin: Clinical Trial Begins Patient Enrollment
    Life sciences company Revive Therapeutics Ltd. 
    Via Benzinga
    Psyched: 12 States Discuss Legalization Bills, Ceremonies For Veterans With TBI, Ketamine And MDMA Fast-Tracks & More
    Psychedelics Legislation: The Latest On Hawaii, Virginia, Missouri & More 
    Via Benzinga
    MDMA News: Optimi's New Drug Now Available, Revive Advances Transdermal Patch Evaluations
    Considering MDMA will likely be the first psychedelic to receive FDA approval for psychotherapeutic use to treat serious mental health conditions such as PTSD, seve 
    Via Benzinga
    PharmaTher Holdings Nabs New Orphan Drug Status, Discusses Further Fast-Track, Partners For MDMA Patch
    Ketamine products manufacturer PharmaTher Holdings Ltd. (OTCQB: PHRRF) had lots happening this past week. Here are the company's top three news items. 
    Via Benzinga
    Psyched: Psychedelics In Davos, Prince Harry In The 90s, Cathie Wood's Latest Moves And More
    Psychedelics Take Center Stage In Davos Psychedelics will lead the conversation inside the Davos House of Health for a second year in a row this January. 
    Via Benzinga
    Psychedelics Company Revive Raises $3.2M To Target Infectious Diseases, Disorders
    Life sciences company Revive Therapeutics Ltd. (OTCQB: RVVTF) raised funds to treat infectious diseases and rare disorders, including meth addiction.< 
    Via Benzinga
    Psyched: First Ayahuasca Pill Created, Psychedelics Legalization Predicted, UK's Research Support And More
    Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans The first medical-grade drug candidate of the psychedelic ayahuasca is being developed. 
    Via Benzinga
    Psyence, Revive Therapeutics Ink Private Placements: Capital To Support Drug Trials
    Life sciences biotech Psyence Group Inc. (OTCQB: PSYGF) has closed the second tranche of its previously announced private placement of up to $2.2 million (CA$3 million). 
    Via Benzinga
    Revive Therapeutics To Raise Up To $5M Via Private Placement
    REVIVE THERAPEUTICS LTD. (OTCQB: RVVTF) (CSE:RVV) announced that it is arranging a private placement of a minimum of $3 million and up to $5 million of units, at a price of $0.15 per unit;. 
    Via Benzinga
    Psychedelic Stock Gainers And Losers From November 30, 2022
    Via Benzinga
    Revive Therapeutics, Seelos Therapeutics Among Top Psychedelic Movers Of Today
    Via Benzinga
    Revive Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
    Via Benzinga
    Psychedelic Stock Gainers And Losers From November 25, 2022
    Via Benzinga
    Psychedelic Stock Gainers And Losers From November 24, 2022
    Via Benzinga
    Psychedelic Stock Gainers And Losers From November 23, 2022
    Via Benzinga
    Psychedelic Stock Gainers And Losers From November 22, 2022
    Via Benzinga
    Psychedelic Stock Gainers And Losers From November 21, 2022
    Via Benzinga
    Biomind Labs, ATAI Life Sciences Among Top Psychedelic Movers Of Today
    Via Benzinga
    Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
    Via Benzinga
    Psychedelic Stock Gainers And Losers From November 16, 2022
    Via Benzinga
    GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today
    Via Benzinga
    Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today
    GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 12.17% at $10.05 
    Via Benzinga
    Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
    GAINERS: GH Research (NASDAQ:GHRS) shares closed up 7.91% at $9.96 LOSERS: 
    Via Benzinga
    Psychedelic Stock Gainers And Losers From November 8, 2022
    GAINERS: Small Pharma (OTC:DMTTF) shares closed up 3.85% at $0.14 
    Via Benzinga
    Compass Pathways, Allied Among Top Psychedelic Movers Of Today
    GAINERS: Allied (OTC:ALID) shares closed up 4.10% at $0.44 
    Via Benzinga
    Psychedelic Stock Gainers And Losers From November 3, 2022
    GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.80% at $10.27 
    Via Benzinga
    Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today
    GAINERS: GH Research (NASDAQ:GHRS) shares closed up 3.90% at $10.39 LOSERS: 
    Via Benzinga
    Revive Therapeutics, Small Pharma Among Top Psychedelic Movers Of Today
    GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 3.00% at $0.87 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.